BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Influenza-related morbidity and mortality remain high. Seasonal vaccination is the backbone of influenza management but does not always result in protective antibody titers. Nonspecific effects of BCG vaccination related to enhanced function of myeloid antigen-presenting cells have been reported. We hypothesized that BCG vaccination could also enhance immune responses to influenza vaccination. METHODS: Healthy volunteers received either live attenuated BCG vaccine (n = 20) or placebo (n = 20) in a randomized fashion, followed by intramuscular injection of trivalent influenza vaccine 14 days later. Hemagglutination-inhibiting (HI) antibodies and cellular immunity measured by ex vivo leukocyte responses were assessed. RESULTS: In BCG-vaccinated subjects, HI antibody responses against the 2009 pandemic influenza A(H1N1) vaccine strain were significantly enhanced, compared with the placebo group, and there was a trend toward more-rapid seroconversion. Additionally, apart from enhanced proinflammatory leukocyte responses following BCG vaccination, nonspecific effects of influenza vaccination were also observed, with modulation of cytokine responses against unrelated pathogens. CONCLUSIONS: BCG vaccination prior to influenza vaccination results in a more pronounced increase and accelerated induction of functional antibody responses against the 2009 pandemic influenza A(H1N1) vaccine strain. These results may have implications for the design of vaccination strategies and could lead to improvement of vaccination efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of Adaptive Immunity by the Innate Immune System
Iwasaki, A., & Medzhitov, R. (2010) · Science · doi:10.1126/science.1183021 · Cited by 2,157
Kleinnijenhuis, J., Quintin, J., Preijers, F., Joosten, L. A. B., Ifrim, D. C., Saeed, S., Jacobs, C., van Loenhout, J., de Jong, D., Stunnenberg, H. G., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202870109 · Cited by 1,728 · cited 6×
“Finally, we based our 14-day interval between BCG and influenza vaccination on previous studies in mice, in which viral challenges were performed 14 to 49 days after BCG vaccination [11], and in humans, in whom non-specific effects of BCG were demonstrated exvivo 14 days after vaccination [15].”
BackgroundMethodInfluentialSelf-citationKleinnijenhuis, J., Quintin, J., Preijers, F., Benn, C. S., Joosten, L. A. B., Jacobs, C., van Loenhout, J., Xavier, R. J., Aaby, P., van der Meer, J. W. M., et al. (2014) · Journal of Innate Immunity · doi:10.1159/000355628 · Cited by 620
Self-citationMurray, C. J., Lopez, A. D., Chin, B., Feehan, D., & Hill, K. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69895-4 · Cited by 605
Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets
Munster, V. J., de Wit, E., van den Brand, J. M. A., Herfst, S., Schrauwen, E. J. A., Bestebroer, T. M., van de Vijver, D., Boucher, C. A., Koopmans, M., Rimmelzwaan, G. F., et al. (2009) · Science · doi:10.1126/science.1177127 · Cited by 598
Self-citationAaby, P., Roth, A., Ravn, H., Napirna, B. M., Rodrigues, A., Lisse, I. M., Stensballe, L., Diness, B. R., Lausch, K. R., Lund, N., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir240 · Cited by 583
A small jab – a big effect: nonspecific immunomodulation by vaccines
Benn, C. S., Netea, M. G., Selin, L. K., & Aaby, P. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.004 · Cited by 514
Self-citationContinuing challenges in influenza
Webster, R. G., & Govorkova, E. A. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12462 · Cited by 399
Coudeville, L., Bailleux, F., Riche, B., Megas, F., Andre, P., & Ecochard, R. (2010) · BMC Medical Research Methodology · doi:10.1186/1471-2288-10-18 · Cited by 374
Immune responses to influenza virus infection
Kreijtz, J. H. C. M., Fouchier, R. A. M., & Rimmelzwaan, G. F. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.022 · Cited by 336
Self-citationOta, M. O. C., Vekemans, J., Schlegel-Haueter, S. E., Fielding, K., Sanneh, M., Kidd, M., Newport, M. J., Aaby, P., Whittle, H., Lambert, P.-H., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.919 · Cited by 288
Immunosenescence: influenza vaccination and the elderly
Haq, K., & McElhaney, J. E. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.03.008 · Cited by 256 · cited 1×
“In addition, vaccination is not always effective, as 85% of healthy adults and only 40-60% of elderly people mount a protective antibody response, due to original antigenic sin [5], and an age-related decline in immune function (a process called immunoscenescence) [6].”
BackgroundBiering-Sørensen, S., Aaby, P., Napirna, B. M., Roth, A., Ravn, H., Rodrigues, A., Whittle, H., & Benn, C. S. (2012) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182458289 · Cited by 226
McElhaney, J. E., Ewen, C., Zhou, X., Kane, K. P., Xie, D., Hager, W. D., Barry, M. B., Kleppinger, A., Wang, Y., & Bleackley, R. C. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.136 · Cited by 218
The Role of BCG/PPD‐Activated Macrophages in Resistance against Systemic Candidiasis in Mice
VAN't WOUT, J. W., POELL, R., & VAN FURTH, R. (1992) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1992.tb03132.x · Cited by 183
The unmet need in the elderly: Designing new influenza vaccines for older adults
McElhaney, J. E. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.019 · Cited by 168
Dormitzer, P. R., Galli, G., Castellino, F., Golding, H., Khurana, S., Del Giudice, G., & Rappuoli, R. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00974.x · Cited by 160
Stöhr, K. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00366-3 · Cited by 158
Aaby, P., Kollmann, T. R., & Benn, C. S. (2014) · Nature Immunology · doi:10.1038/ni.2961 · Cited by 148
Comparison of the Pathology Caused by H1N1, H5N1, and H3N2 Influenza Viruses
Guarner, J., & Falcón-Escobedo, R. (2009) · Archives of Medical Research · doi:10.1016/j.arcmed.2009.10.001 · Cited by 137
Ritz, N., Mui, M., Balloch, A., & Curtis, N. C. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.03.059 · Cited by 126
Influenza Vaccines: From Surveillance Through Production to Protection
Tosh, P. K., Jacobson, R. M., & Poland, G. A. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0615 · Cited by 121
Belshe, R. B., Newman, F. K., Wilkins, K., Graham, I. L., Babusis, E., Ewell, M., & Frey, S. E. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.066 · Cited by 107
Immunosenescence and Influenza Vaccine Efficacy
Sambhara, S., & McElhaney, J. E. (2009) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-92165-3_20 · Cited by 95
Bacillus Calmette-Guérin vaccination and infant mortality
Roth, A., Garly, M. ‐., Jensen, H., Nielsen, J. O., & Aaby, P. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.2.277 · Cited by 92
[Effect of Bacillus Callmette Guerin (BCG) on the receptivity of nude mice to Schistosoma mansoni].
Tribouley, J., Tribouley-Duret, J., & Appriou, M. (1978) · PubMed · Cited by 76
Increased resistance to virus infections of mice inoculated with BCG (Bacillus calmette-guérin).
Floc'h, F., & Werner, G. H. (1976) · PubMed · Cited by 59
Libraty, D. H., Zhang, L., Woda, M., Acosta, L. P., Obcena, A., Brion, J. D., & Capeding, R. Z. (2013) · Trials in Vaccinology · doi:10.1016/j.trivac.2013.11.004 · Cited by 56
Mostow, S. R., Schoenbaum, S. C., Dowdle, W. R., Coleman, M. T., & Kaye, H. S. (1973) · Postgraduate Medical Journal · doi:10.1136/pgmj.49.569.152 · Cited by 31
Cited by
Defining trained immunity and its role in health and disease
Netea, M. G., Domínguez-Andrés, J., Barreiro, L. B., Chavakis, T., Divangahi, M., Fuchs, E., Joosten, L. A. B., van der Meer, J. W. M., Mhlanga, M. M., Mulder, W. J. M., et al. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0285-6 · Cited by 2,690
Self-citationArts, R. J. W., Moorlag, S. J. C. F. M., Novakovic, B., Li, Y., Wang, S.-Y., Oosting, M., Kumar, V., Xavier, R. J., Wijmenga, C., Joosten, L. A. B., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2017.12.010 · Cited by 1,179
Self-citationNon-specific effects of BCG vaccine on viral infections
Moorlag, S. J. C. F. M., Arts, R. J. W., van Crevel, R., & Netea, M. G. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.020 · Cited by 479
Self-citationActivate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly
Giamarellos-Bourboulis, E. J., Tsilika, M., Moorlag, S., Antonakos, N., Kotsaki, A., Domínguez-Andrés, J., Kyriazopoulou, E., Gkavogianni, T., Adami, M.-E., Damoraki, G., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.051 · Cited by 407
Self-citationDheda, K., Perumal, T., Moultrie, H., Perumal, R., Esmail, A., Scott, A. J., Udwadia, Z., Chang, K. C., Peter, J., Pooran, A., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00092-3 · Cited by 292
Metadata
- Authors
- Leentjens, J., Kox, M., Stokman, R., Gerretsen, J., Diavatopoulos, D. A., van Crevel, R., Rimmelzwaan, G. F., Pickkers, P., & Netea, M. G.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-06-12
- Volume
- 212
- Issue
- 12
- Pages
- 1930-1938
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W1941977522
- Cited by
- 255
- References
- 29
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.